
Washington – Defense Secretary Pete Hegseth’s new initiative to test and treat soldiers with low testosterone levels has led a federal judge to question the differences between that type of testosterone replacement therapy and hormone treatment for transgender men in the military.
U.S. District Judge Ana Reyes of Washington raised the issue Wednesday in an ongoing lawsuit against President Donald Trump’s ban on transgender soldiers serving in the Armed Forces. Reyes noted that Trump’s ban states that “the Armed Forces must meet high standards of mental and physical health… without being able to benefit from routine medical treatments or special provisions.”
Reyes ordered both sides in the litigation to address “the similarities and differences in the administration of TRT, both medically and logistically, for trans men compared to other members of the Armed Forces, including cis people.” He used the acronym TRT for “testosterone replacement therapy.”
The judge also requested information about “the basis on which the Pentagon bases its treatment of trans men and other members of the Armed Forces differently in this new policy and in the military ban.”
Reyes’ order comes a week after Hegseth announced that he is launching a new screening program for “testosterone deficiency” among soldiers, calling it necessary so they can perform at the “highest level.”
The tests will be carried out annually as part of the mandatory medical examinations for members of the Armed Forces over 30 years of age, he stated. Military personnel under 30 years of age can undergo testing voluntarily. In a video posted on social media, Hegseth noted that receiving testosterone replacement therapy would be voluntary.
Other officials in the Trump administration have begun advocating for men to have easier access to testosterone replacement therapies, but the message from Hegseth and others mixes the known scientific knowledge about this hormone with more general and less substantiated claims.
Testosterone levels in men naturally decline with age and have long been linked to problems such as erectile dysfunction, decreased libido, mood swings, and weight gain. However, experts have been debating for years how to diagnose these problems and whether they should be treated with hormone replacement therapy.
Reyes, appointed by President Joe Biden, is in charge of one of the legal proceedings against Trump’s ban on transgender military personnel. Transgender active-duty military members and former military members seeking to rejoin filed a lawsuit in late January 2025, shortly after the president took office for his second term.
Reyes ruled last year against Trump’s executive order to exclude transgender service members. A federal appeals court, with divided opinions, returned the case to Reyes after partially confirming his resolution, considering that the ban was illegal and that the soldiers who had filed the lawsuit could not be expelled.
Reyes has since admitted the lawsuit as a class action, meaning the ruling could be extended to all members of the Armed Forces.
However, Trump’s ban on transgender people serving in the military remains in place. The United States Supreme Court has allowed the Pentagon to apply it while the litigation is resolved.
This story was translated from English to Spanish with an artificial intelligence tool and was reviewed by an editor before publication.
